Key facts
- Passage Health’s last known valuation is $46.0M (May 2025).
- It has raised $10.2M across 2 recorded rounds; the latest was Early Stage VC ($8.0M) in Apr 2025.
- Notable investors include Sovereign's Capital, Fractal Software, LivEdge Capital, Telescope Partners.
- Passage Health has filed 2 Form Ds with the SEC since 2023, most recently May 2025 ($8.0M sold to 2 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Passage Health
Funding rounds
2 roundsAbout Passage Health
Developer of an ABA clinical software designed to improve the quality and accessibility of care available to people with autism. The company's software offers intuitive data collection, builds treatment plans, enhances supervision tools, and notifies when treatment progress slows down, enabling clinical practitioners to enhance the quality of care and improve the lives of the patients.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2022
- Employees
- 31
- Website
- passagehealth.com/
- Ownership
- Privately Held (backing)
Passage Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Passage Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Passage Health in its N-PORT filings yet. We sweep new filings monthly.